Usefulness of mean platelet volume as a biomarker for long-term clinical outcomes after percutaneous coronary intervention in Korean cohort: A comparable and additive predictive value to high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide

Platelets

Volumn 25, Issue 6, 2014, Pages 427-432

  Ki, Young Jae ^a   Park, Seulki ^a   Ha, Sung Il ^a   Choi, Dong Hyun ^a   Song, Heesang ^a  

^a Chosun University   (South Korea)

Author keywords

Cardiac death; High sensitivity cardiac troponin T; Mean platelet volume; N terminal pro B type natriuretic peptide; Percutaneous coronary intervention

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; TROPONIN T; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADVERSE OUTCOME; AGED; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; KAPLAN MEIER METHOD; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REVASCULARIZATION; RISK ASSESSMENT; STENT THROMBOSIS; TARGET VESSEL REVASCULARIZATION; THROMBOCYTE VOLUME; ADVERSE EFFECTS; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; SOUTH KOREA; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; REPUBLIC OF KOREA; SURVIVAL RATE; TROPONIN T;

EID: 84920661070     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2013.835393     Document Type: Article

References (16)

1. Shanker J Gasparyan AY Kitas GD Kakkar VV. Platelet function and antiplatelet therapy in cardiovascular disease: Implications of genetic polymorphisms. Curr Vasc Pharmacol 2011;9:479-489.
2. Gasparyan AY Watson T Lip GY. The role of aspirin in cardiovascular prevention: Implications of aspirin resistance. J Am Coll Cardiol 2008;51:1829-1843.
3. Snoep JD Hovens MM Eikenboom JC van der Bom JG Jukema JW Huisman MV. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis. Am Heart J 2007;154: 221-231.
4. Patti G Nusca A Mangiacapra F Gatto L D'Ambrosio A Di Sciascio G. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the armyda-pro (antiplatelet therapy for reduction of myocardial damage during angioplastyplatelet reactivity predicts outcome) study. J Am Coll Cardiol 2008; 52:1128-1133.
5. Price MJ Endemann S Gollapudi RR Valencia R Stinis CT Levisay JP Ernst A Sawhney NS Schatz RA Teirstein PS. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drugeluting stent implantation. Eur H J 2008;29:992-1000.
6. Bonello L Pansieri M Mancini J Bonello R Maillard L Barnay P Rossi P Ait-Mokhtar O Jouve B Collet F et al. High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes. J Am Coll Cardiol 2011;58:467-473.
7. Gasparyan AY Ayvazyan L Mikhailidis DP Kitas GD. Mean platelet volume: A link between thrombosis and inflammation? Curr Pharmaceut Design 2011;17:47-58.
8. Huczek Z Kochman J Filipiak KJ Horszczaruk GJ Grabowski M Piatkowski R Wilczynska J Zielinski A Meier B Opolski G. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005;46:284-290.
9. Goncalves SC Labinaz M Le May M Glover C Froeschl M Marquis JF O'Brien E Shukla D Ruchin P Sookur D et al. Usefulness of mean platelet volume as a biomarker for long-term outcomes after percutaneous coronary intervention. Am J Cardiol 2011;107:204-209.
10. Yang A Pizzulli L Luderitz B. Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thrombosis Res 2006;117:371-377.
11. Cutlip DE Windecker S Mehran R Boam A Cohen DJ van Es GA Steg PG Morel MA Mauri L Vranckx P et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
12. Ha SI Choi DH Ki YJ Yang JS Park G Chung JW Koh YY Chang KS Hong SP. Stroke prediction using mean platelet volume in patients with atrial fibrillation. Platelets 2011;22:408-414.
13. Han JY Choi DH Choi SW Kim BB Ki YJ Chung JW Koh YY Chang KS Hong SP. Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2013;24:401-406.
14. Chu SG Becker RC Berger PB Bhatt DL Eikelboom JW Konkle B Mohler ER Reilly MP Berger JS. Mean platelet volume as a predictor of cardiovascular risk: A systematic review and meta-analysis. J Thrombosis Haemostasis: JTH 2010;8: 148-156.
15. Shah B Oberweis B Tummala L Amoroso NS Lobach I Sedlis SP Grossi E Berger JS. Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol 2013;111:185-189.
16. Choi SW Choi DH Kim HW Ku YH Ha SI Park G. Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in korean cohort: Implications of more simple and useful test than platelet function testing. Platelets 2013; 24 [epub ahead of print].